Ireland
--:--IST
Recruiting Observational

German Hypoparathyroidism Registry

NCT07857460 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2021-07-06
Last updated
2026-10-05

Condition(s) studied

HypoparathyroidismPseudohypoparathyroidism

Study summary

Chronic hypoparathyroidism is a rare condition in which the parathyroid glands do not make enough parathyroid hormone (PTH). PTH helps control the levels of calcium and phosphate in the blood. When there is not enough PTH, calcium levels can become too low and phosphate levels can become too high. This may cause symptoms such as tingling, muscle cramps, weakness, or other health problems.

The most common cause of chronic hypoparathyroidism is surgery in the neck area. It can happen after thyroid surgery, surgery on the parathyroid glands, or other operations in the neck.

At the moment, most patients are treated with calcium and vitamin D tablets. These treatments help control calcium levels, but they cannot fully replace the normal effects of PTH in the body. A medicine that contains a form of human PTH is available for some patients, but it is not yet the standard treatment for everyone.

This registry collects medical information and follows patients over time. Its aim is to better understand patients' symptoms, possible long-term health problems, treatments, and overall health. A group of patients who have had their thyroid removed but do not have hypoparathyroidism will also be included for comparison.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * diagnosis of chronic hypo- or pseudohypoparathyroidism \> 6 months or diagnosis of pseudohypoparathyroidism * age \>= 18 yrs. * residing in Germany * Written consent for patients capable of giving informed consent Exclusion Criteria: * Minors and patients with severe mental illnesses, or patients who are unable to provide written informed consent. Controll group * h/o thyroidektomy with thyroid hormone replacement * age \>= 18 yrs. * residing in Germany * The exclusion criteria also apply to this group.

Primary outcome measure(s)

  • long-term comorbidities in hypoparathyroidism — 15 years
    compared with a controll group

Trial sites (1)

FacilityCityRegionStatus
University Hospital Augsburg Augsburg Bavaria Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07857460 on ClinicalTrials.gov ↗ ← All trials in Germany